PharmGKB summary: very important pharmacogene information for MT-RNR1

Pharmacogenet Genomics. 2016 Dec;26(12):558-567. doi: 10.1097/FPC.0000000000000247.

Authors

Julia M Barbarino¹, Tracy L McGregor, Russ B Altman, Teri E Klein

Affiliation

¹ Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Pediatrics, Division of Medical Genetics and Genomic Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Aminoglycosides / therapeutic use
Anti-Bacterial Agents / therapeutic use
DNA, Mitochondrial / genetics*
Genetic Predisposition to Disease
Genetic Variation
Hearing Loss / drug therapy
Hearing Loss / genetics*
Hearing Loss / pathology
Humans
Mutation
Pharmacogenetics*
RNA, Ribosomal / genetics*
Ribonucleotide Reductases / genetics*

Substances

Aminoglycosides
Anti-Bacterial Agents
DNA, Mitochondrial
RNA, Ribosomal
RNA, ribosomal, 12S
Ribonucleotide Reductases

Grants and funding